Mytanne (Mitotane) 500mg 100 Tablets | TLPH Laos Generic | GLT

Generic Information: Mytanne (Mitotane) — Tongmeng (TLPH) Laos Generic

Mytanne is the mitotane product of Tongmeng (Lao) Pharmaceutical and Food Co., Ltd. — the company widely known by its TLPH mark — based in Vientiane, Laos. Its official English prescribing document lists the marketing authorization holder as Tongmeng (Lao) Pharmaceutical and Food Co., Ltd., and the tablets themselves carry the "TLPH" imprint on one side, a useful authenticity check. Laos first approved Mytanne in 2016, and the Lao FDD renewed the registration on 20 September 2023, taking the product into its second decade — meaningful continuity for a drug with such a small patient population. Each bottle holds 100 white, biconvex 500 mg tablets.

What Is Mytanne (Mitotane) Used For?

Mytanne treats the same condition as the original: inoperable, functional or nonfunctional adrenocortical carcinoma, together with adrenocortical hyperplasia and the cortisol excess produced by hormone-secreting tumors. For patients in Southeast Asia and beyond who cannot reach or afford the originator, a documented Lao generic is the practical difference between treatment and none at all — and mitotane, as an orphan drug, is exactly the medicine where a generic alternative matters most, because the patient population is too small to attract many manufacturers.

How Does Mytanne (Mitotane) Work?

The active ingredient is mitotane, an adrenal cytotoxic agent with a dual effect: it destroys adrenocortical cells by disrupting mitochondrial function and inhibiting SOAT1, and it suppresses the adrenal's steroid production, cutting the cortisol, aldosterone and androgen output that drive symptoms in functional tumors. The tablet's inactive ingredients are maize starch, microcrystalline cellulose, macrogol 3350 and colloidal anhydrous silica — a standard, well-tolerated formulation. As with all mitotane, the drug is lipophilic and clears very slowly, so treatment is managed by blood-level titration rather than fixed dosing.

Indications of Mytanne (Laos)

The Lao label covers inoperable functional and nonfunctional adrenocortical carcinoma, adrenocortical hyperplasia, and cortisol excess from hormone-producing tumors — the broad reading of mitotane's use that includes the Cushing's syndrome management international practice recognizes. The product is indicated for adults; pediatric safety has not been established, and elderly patients are generally started at the low end of the dose range.

Dosage and Administration

Treatment typically starts in the range of 6–15 mg per kilogram per day, divided into three or four oral doses, beginning low and increasing to the maximum tolerated level — commonly between 2 g and 6 g daily, and up to 8–10 g per day in some patients. The goal is a plasma mitotane level of 14–20 mg/L. Tablets are swallowed whole with food and never crushed or chewed. Because levels drift slowly, dose changes are made gradually and monitored; after a good clinical response the dose is usually reduced to a lower maintenance range. Treatment should be supervised by a physician experienced with mitotane.

Side Effects of Mytanne

The most common effects (≥15%) are anorexia, nausea, vomiting, diarrhea, depression, dizziness or vertigo, and rash. The serious risks are identical to the originator's: adrenal insufficiency requiring steroid replacement, central nervous system toxicity that climbs sharply above 20 mg/L, hepatotoxicity, hematologic changes, and the boxed-warning risk of adrenal crisis during shock, trauma or infection. Mytanne can harm a fetus, so effective nonhormonal contraception is required during treatment and while the drug remains detectable afterward; breastfeeding is not recommended.

Storage Instructions

Store at 25°C, with short excursions allowed between 15°C and 30°C, in the original bottle away from light and moisture. Keep out of children's reach, and return unused tablets to a pharmacy for safe disposal — mitotane is a cytotoxic agent.

Why Choose Mytanne from GLT?

Mytanne's appeal is continuity and verifiability: a Lao product with a public registration history stretching back to 2016, a renewed 2023 license, and a maker — Tongmeng/TLPH — whose imprint is literally on every tablet. GLT adds the verification layer generics buying actually hinges on: sealed bottles, batch documentation, pre-shipment photographs of the exact stock we will send, and a human being on the other end of WhatsApp +86 15234153837 and [email protected]. We price Mytanne fairly and will quote it against the US, EU, China and other Lao presentations so you choose on numbers, not guesswork.

How to Order Mytanne (Mitotane)

Send your quantity to WhatsApp +86 15234153837 or [email protected]. GLT replies with a formal quotation, courier options and payment details — usually within one working day — and dispatches sealed stock with export documentation on confirmation. Multi-month supply can be scheduled to prevent any gap in a continuous therapy.

FAQ

Who makes Mytanne? Tongmeng (Lao) Pharmaceutical and Food Co., Ltd. — the company behind the TLPH mark — which holds the marketing authorization; the tablets carry the TLPH imprint.

How long has Mytanne been available? It was first approved in Laos in 2016, and its registration was renewed on 20 September 2023, so it has been in continuous use for close to a decade.

Is Mytanne the same strength as Lysodren? Yes — 500 mg per tablet, 100 tablets per bottle, matching the original's standard presentation.

What is the maximum daily dose? Dosing is individualized to blood levels; some patients reach 8–10 g per day, but the target is the 14–20 mg/L therapeutic window, not a fixed maximum.

Can it be used for Cushing's syndrome? The Lao label includes cortisol excess from hormone-producing tumors, which covers the Cushing's syndrome management international practice recognizes.